General Hospital of Nikaia-Piraeus, “Agios Panteleimon”
- Address
- lock Available on a paid plan
Digestive System Diseases and Inflammatory Bowel Disease Research
At General Hospital of Nikaia-Piraeus, “Agios Panteleimon”, clinical research in digestive system diseases focuses on Crohn’s Disease and the search for better ways to control inflammation in adults who have not responded well to earlier treatment. These studies are designed to compare the effectiveness and safety of new therapy options and to support longer-term disease management.
- Comparing treatment effectiveness in Crohn’s Disease
- Evaluating long-term safety in gastroenterology
- Supporting sustained access to care for patients with chronic intestinal inflammation
This area reflects a strong interest in improving outcomes for people living with persistent inflammatory bowel disease, with attention to both symptom control and treatment safety over time.
Diseases of the Kidneys and Pathological Conditions
Research in IgA Nephropathy at this site aims to better understand how to reduce kidney damage and protein loss in adults affected by this immune-mediated renal disease. The trials are centered on testing whether new treatment approaches can improve disease control and protect kidney function.
- Studying proteinuria reduction in IgA Nephropathy
- Assessing potential new options for kidney disease treatment
- Exploring ways to slow progression of chronic renal injury
This work highlights a focused effort in nephrology to improve both measurable kidney outcomes and overall patient care.
Respiratory Tract Diseases and Infection Management
The site also conducts studies in community-acquired pneumonia and severe infections, with an emphasis on improving diagnosis and guiding antibiotic use more effectively. These trials seek to reduce unnecessary broad-spectrum treatment and help prevent worsening illness, including progression to sepsis.
- Improving treatment decisions in community-acquired pneumonia
- Reducing overuse of antibiotics in serious infections
- Testing biomarker-guided approaches for earlier infection control
This research combines respiratory medicine and infectious disease expertise to support more targeted and timely care for patients at higher risk.
Musculoskeletal Diseases and Knee and Back Pain Research
In the department of Sports Injuries and Knee Surgery, studies in musculoskeletal diseases include work on low back pain, a common condition that can significantly limit daily activity. The trials are aimed at evaluating whether new pain-relief strategies can improve comfort and function more effectively than existing options.
- Testing treatment options for acute severe low back pain
- Comparing pain relief and tolerability approaches
- Supporting better management of movement-related pain
This area shows a practical focus on orthopedic and pain management research that may help patients recover mobility and return to normal activities sooner.
Bacterial Infections and Mycoses and Clinical Biomarker Research
Another important part of the research portfolio involves bacterial infections, where trials are examining ways to improve the diagnosis and treatment of severe infectious illness. The main purpose is to make therapy more precise by using clinical indicators that can guide decisions earlier in the course of care.
- Evaluating tools for earlier infection diagnosis
- Improving targeted treatment for severe infections
- Supporting safer and more effective antimicrobial use
This line of research brings together microbiology and clinical decision support to help clinicians choose treatments that are more precise and potentially more effective.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Verisfield Single Member S.A.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 173 other sites in Greece
Therapeutic Area Benchmark — Greece
Select a therapeutic area to compare against other sites in Greece.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Greece
Market Share
Country: Greece
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in General Hospital of Nikaia-Piraeus, “Agios Panteleimon”
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Atacicept in Adult Patients with IgA Nephropathy: A Phase 2b/3 Randomized, Double-Blind, Placebo-Controlled Study | Vera Therapeutics Inc. | Phase IV | Not Recruiting | Sep 2021 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Atacicept | 1 | Unknown | 2021-09-15 | 2021-09-15 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
